PDL BIOPHARMA, INC. 3 SEC Filings

Filed On	Filing
11 Jan 2021	Form 3: Park West Asset Management Llc, 10% owner Holds 14,397,212 shares of Common stock, par value $0.01
15 Dec 2020	Form 3: Silver Point Capital L.p., 10% owner and 2 others Holds 11,423,460 shares of Common Stock
17 Sep 2020	Form 3: Pdl BIOPHARMA, Inc., 10% owner · LENSAR Inc Holds 8,658,694 shares of Common Stock
21 Apr 2020	Form 3: Bazaar Alan Lee, Director No securities owned
24 Jun 2019	Form 3: Hernday Natasha, Director No securities owned
24 Jun 2019	Form 3: Imbrogno Edward, VP, Finance and CAO Holds 22,357 shares of Common stock
18 Apr 2019	Form 3: Pdl BIOPHARMA, Inc., 10% owner · Evofem Biosciences Inc Holds 6,666,667 shares of Common Stock
25 Jun 2018	Form 3: O'Farrell Elizabeth G., Director No securities owned
12 Jun 2018	Form 3: Jene Jill M., VP, Business Development No securities owned
12 Jun 2018	Form 3: Yanai Shlomo, Director No securities owned
13 Sep 2017	Form 3: Monnet Dominique, President No securities owned
16 Sep 2015	Form 3: Saks Samuel R, Director No securities owned
08 Sep 2015	Form 3: Edick Paul R, Director No securities owned
02 Jul 2015	Form 3: Pietzke Steffen, Controller and CAO No securities owned
24 Jun 2015	Form 3: Immune Response BioPharma, Inc., Shareholder Holds 1 shares of PDL Stock
10 Mar 2014	Form 3: Gryska David W, Director No securities owned
29 Jul 2013	Form 3: Montez David, Controller and CAO No securities owned
16 May 2013	Form 3: Garcia Peter S, Vice President, CFO No securities owned
13 Jun 2012	Form 3: Tomlinson Bruce, Chief Financial Officer No securities owned
20 Apr 2011	Form 3: Hart Danny J Jr., Assoc Genl Counsel/Asst Sec Holds 2,000 shares of Common Stock

Comments